Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 455 entries
Sorted by: Best Match Show Resources per page
Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism.

International journal of endocrinology

Moyes VJ, Monson JP, Chew SL, Akker SA.
PMID: 20585352
Int J Endocrinol. 2010;2010:906163. doi: 10.1155/2010/906163. Epub 2010 May 26.

Background. Management of multiple-endocrine neoplasia type 1- (MEN1-) associated hyperparathyroidism is associated with high recurrence rates and high surgical morbidity due to multiple neck explorations. Cinacalcet, a calcimimetic agent licensed for the treatment of secondary hyperparathyroidism and parathyroid carcinoma,...

Cite
Moyes VJ, Monson JP, Chew SL, et al. Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism. Int J Endocrinol. 2010;2010:906163doi: 10.1155/2010/906163.
Moyes, V. J., Monson, J. P., Chew, S. L., & Akker, S. A. (2010). Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism. International journal of endocrinology, 2010906163. https://doi.org/10.1155/2010/906163
Moyes, V J, et al. "Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism." International journal of endocrinology vol. 2010 (2010): 906163. doi: https://doi.org/10.1155/2010/906163
Moyes VJ, Monson JP, Chew SL, Akker SA. Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism. Int J Endocrinol. 2010;2010:906163. doi: 10.1155/2010/906163. Epub 2010 May 26. PMID: 20585352; PMCID: PMC2877200.
Copy Download .nbib Format: NLM
Optical parametric amplifiers: a discrete dynamical model of singly resonant operation leading to a novel approach to the design of systems for high-efficiency amplification: errata.

Applied optics

Anker DS.
PMID: 21127608
Appl Opt. 1996 Oct 20;35(30):5960. doi: 10.1364/AO.35.005960.

No abstract available.

Cite
Anker DS. Optical parametric amplifiers: a discrete dynamical model of singly resonant operation leading to a novel approach to the design of systems for high-efficiency amplification: errata. Appl Opt. 1996;35(30):5960doi: 10.1364/AO.35.005960.
Anker, D. S. (1996). Optical parametric amplifiers: a discrete dynamical model of singly resonant operation leading to a novel approach to the design of systems for high-efficiency amplification: errata. Applied optics, 35(30), 5960. https://doi.org/10.1364/AO.35.005960
Anker, D S. "Optical parametric amplifiers: a discrete dynamical model of singly resonant operation leading to a novel approach to the design of systems for high-efficiency amplification: errata." Applied optics vol. 35,30 (1996): 5960. doi: https://doi.org/10.1364/AO.35.005960
Anker DS. Optical parametric amplifiers: a discrete dynamical model of singly resonant operation leading to a novel approach to the design of systems for high-efficiency amplification: errata. Appl Opt. 1996 Oct 20;35(30):5960. doi: 10.1364/AO.35.005960. PMID: 21127608.
Copy Download .nbib Format: NLM
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.

Clinical ophthalmology (Auckland, N.Z.)

Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S.
PMID: 21188154
Clin Ophthalmol. 2010 Dec 06;4:1427-32. doi: 10.2147/OPTH.S15136.

PURPOSE: This pilot study investigated whether high-resolution spectral-domain optical coherence tomography (SD-OCT) could detect differences in inner retinal layer (IRL), peripapillary retinal nerve fiber layer (RNFL), and macular thickness between patients with Parkinson's disease (PD) and controls.METHODS: Both eyes...

Cite
Aaker GD, Myung JS, Ehrlich JR, et al. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010;4:1427-32doi: 10.2147/OPTH.S15136.
Aaker, G. D., Myung, J. S., Ehrlich, J. R., Mohammed, M., Henchcliffe, C., & Kiss, S. (2010). Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clinical ophthalmology (Auckland, N.Z.), 41427-32. https://doi.org/10.2147/OPTH.S15136
Aaker, Grant D, et al. "Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 1427-32. doi: https://doi.org/10.2147/OPTH.S15136
Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010 Dec 06;4:1427-32. doi: 10.2147/OPTH.S15136. PMID: 21188154; PMCID: PMC3000768.
Copy Download .nbib Format: NLM
Linear and nonlinear dynamics of matter wave packets in periodic potentials.

Optics express

Anker T, Albiez M, Eiermann B, Taglieber M, Oberthaler M.
PMID: 19471507
Opt Express. 2004 Jan 12;12(1):11-8. doi: 10.1364/opex.12.000011.

We investigate experimentally and theoretically the nonlinear propagation of 87Rb Bose Einstein condensates in a trap with cylindrical symmetry. An additional weak periodic potential which encloses an angle with the symmetry axis of the waveguide is applied. The observed...

Cite
Anker T, Albiez M, Eiermann B, et al. Linear and nonlinear dynamics of matter wave packets in periodic potentials. Opt Express. 2004;12(1):11-8doi: 10.1364/opex.12.000011.
Anker, T., Albiez, M., Eiermann, B., Taglieber, M., & Oberthaler, M. (2004). Linear and nonlinear dynamics of matter wave packets in periodic potentials. Optics express, 12(1), 11-8. https://doi.org/10.1364/opex.12.000011
Anker, Th, et al. "Linear and nonlinear dynamics of matter wave packets in periodic potentials." Optics express vol. 12,1 (2004): 11-8. doi: https://doi.org/10.1364/opex.12.000011
Anker T, Albiez M, Eiermann B, Taglieber M, Oberthaler M. Linear and nonlinear dynamics of matter wave packets in periodic potentials. Opt Express. 2004 Jan 12;12(1):11-8. doi: 10.1364/opex.12.000011. PMID: 19471507.
Copy Download .nbib Format: NLM
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study.

Journal of graduate medical education

Han JE, Trammell AR, Finklea JD, Udoji TN, Dressler DD, Honig EG, Abraham P, Ander DS, Cotsonis GA, Martin GS, Schulman DA.
PMID: 25210581
J Grad Med Educ. 2014 Sep;6(3):501-6. doi: 10.4300/JGME-D-13-00420.1.

BACKGROUND: Simulation training is widely accepted as an effective teaching tool, especially for dealing with high-risk situations.OBJECTIVE: We assessed whether standardized, simulation-based advanced cardiac life support (ACLS) training improved performance in managing simulated and actual cardiac arrests.METHODS: A total...

Cite
Han JE, Trammell AR, Finklea JD, et al. Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study. J Grad Med Educ. 2014;6(3):501-6doi: 10.4300/JGME-D-13-00420.1.
Han, J. E., Trammell, A. R., Finklea, J. D., Udoji, T. N., Dressler, D. D., Honig, E. G., Abraham, P., Ander, D. S., Cotsonis, G. A., Martin, G. S., & Schulman, D. A. (2014). Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study. Journal of graduate medical education, 6(3), 501-6. https://doi.org/10.4300/JGME-D-13-00420.1
Han, Jenny E, et al. "Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study." Journal of graduate medical education vol. 6,3 (2014): 501-6. doi: https://doi.org/10.4300/JGME-D-13-00420.1
Han JE, Trammell AR, Finklea JD, Udoji TN, Dressler DD, Honig EG, Abraham P, Ander DS, Cotsonis GA, Martin GS, Schulman DA. Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study. J Grad Med Educ. 2014 Sep;6(3):501-6. doi: 10.4300/JGME-D-13-00420.1. PMID: 25210581; PMCID: PMC4160059.
Copy Download .nbib Format: NLM
Cachexia as a major public health problem: frequent, costly, and deadly.

Journal of cachexia, sarcopenia and muscle

Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M.
PMID: 23539127
J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):173-8. doi: 10.1007/s13539-013-0105-y. Epub 2013 Mar 29.

Perception of healthy body size and composition differs considerably across the globe, ethnic groups, cultures, and even inside medical community. Although the concept of ideal body weight has evolved over the past decades, the observation that weight loss can...

Cite
Farkas J, von Haehling S, Kalantar-Zadeh K, et al. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013;4(3):173-8doi: 10.1007/s13539-013-0105-y.
Farkas, J., von Haehling, S., Kalantar-Zadeh, K., Morley, J. E., Anker, S. D., & Lainscak, M. (2013). Cachexia as a major public health problem: frequent, costly, and deadly. Journal of cachexia, sarcopenia and muscle, 4(3), 173-8. https://doi.org/10.1007/s13539-013-0105-y
Farkas, Jerneja, et al. "Cachexia as a major public health problem: frequent, costly, and deadly." Journal of cachexia, sarcopenia and muscle vol. 4,3 (2013): 173-8. doi: https://doi.org/10.1007/s13539-013-0105-y
Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):173-8. doi: 10.1007/s13539-013-0105-y. Epub 2013 Mar 29. PMID: 23539127; PMCID: PMC3774921.
Copy Download .nbib Format: NLM
Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil.

Genes & nutrition

Harsløf LB, Damsgaard CT, Hellgren LI, Andersen AD, Vogel U, Lauritzen L.
PMID: 24643342
Genes Nutr. 2014 May;9(3):396. doi: 10.1007/s12263-014-0396-4. Epub 2014 Mar 19.

Long-chain n-3 fatty acids (n-3 LCPUFA) improve blood pressure (BP) and lipid profile in adults and improve insulin sensitivity in rodents. We have previously shown that n-3 LCPUFA reduces BP and plasma triacylglycerol (TAG) in infants. Few studies have...

Cite
Harsløf LB, Damsgaard CT, Hellgren LI, et al. Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil. Genes Nutr. 2014;9(3):396doi: 10.1007/s12263-014-0396-4.
Harsløf, L. B., Damsgaard, C. T., Hellgren, L. I., Andersen, A. D., Vogel, U., & Lauritzen, L. (2014). Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil. Genes & nutrition, 9(3), 396. https://doi.org/10.1007/s12263-014-0396-4
Harsløf, Laurine B S, et al. "Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil." Genes & nutrition vol. 9,3 (2014): 396. doi: https://doi.org/10.1007/s12263-014-0396-4
Harsløf LB, Damsgaard CT, Hellgren LI, Andersen AD, Vogel U, Lauritzen L. Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil. Genes Nutr. 2014 May;9(3):396. doi: 10.1007/s12263-014-0396-4. Epub 2014 Mar 19. PMID: 24643342; PMCID: PMC4026428.
Copy Download .nbib Format: NLM
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.

Archives of medical science : AMS

Anker MS, von Haehling S, Springer J, Banach M, Anker SD.
PMID: 23515589
Arch Med Sci. 2013 Feb 21;9(1):166-71. doi: 10.5114/aoms.2013.33356.

Sarcopenia and cachexia are significant medical problems with a high disease-related burden in cardiovascular illness. Muscle wasting and weight loss are very frequent particularly in chronic heart failure and they relate to poor prognosis. Although clinically largely underestimated, the...

Cite
Anker MS, von Haehling S, Springer J, et al. Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci. 2013;9(1):166-71doi: 10.5114/aoms.2013.33356.
Anker, M. S., von Haehling, S., Springer, J., Banach, M., & Anker, S. D. (2013). Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Archives of medical science : AMS, 9(1), 166-71. https://doi.org/10.5114/aoms.2013.33356
Anker, Markus S, et al. "Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology." Archives of medical science : AMS vol. 9,1 (2013): 166-71. doi: https://doi.org/10.5114/aoms.2013.33356
Anker MS, von Haehling S, Springer J, Banach M, Anker SD. Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci. 2013 Feb 21;9(1):166-71. doi: 10.5114/aoms.2013.33356. PMID: 23515589; PMCID: PMC3598129.
Copy Download .nbib Format: NLM
Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival.

ESC heart failure

Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, Majda J, von Haehling S, Doehner W, Banasiak W, Anker SD, Ponikowski P.
PMID: 28834667
ESC Heart Fail. 2014 Sep;1(1):41-51. doi: 10.1002/ehf2.12002.

BACKGROUND: Male ageing is characterized by diminished circulating androgens with several adverse psychosomatic consequences and can be aggravated by concomitant chronic diseases. According to the European Male Aging Study (EMAS) Group, late-onset hypogonadism (LOH) refers to testosterone deficiency accompanied...

Cite
Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, et al. Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC Heart Fail. 2014;1(1):41-51doi: 10.1002/ehf2.12002.
Jankowska, E. A., Tkaczyszyn, M., Węgrzynowska-Teodorczyk, K., Majda, J., von Haehling, S., Doehner, W., Banasiak, W., Anker, S. D., & Ponikowski, P. (2014). Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC heart failure, 1(1), 41-51. https://doi.org/10.1002/ehf2.12002
Jankowska, Ewa A, et al. "Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival." ESC heart failure vol. 1,1 (2014): 41-51. doi: https://doi.org/10.1002/ehf2.12002
Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, Majda J, von Haehling S, Doehner W, Banasiak W, Anker SD, Ponikowski P. Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC Heart Fail. 2014 Sep;1(1):41-51. doi: 10.1002/ehf2.12002. PMID: 28834667.
Copy Download .nbib Format: NLM
Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure.

ESC heart failure

Anker SD, von Haehling S, Papp Z.
PMID: 28834670
ESC Heart Fail. 2014 Sep;1(1):1-3. doi: 10.1002/ehf2.12004.

No abstract available.

Cite
Anker SD, von Haehling S, Papp Z. Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC Heart Fail. 2014;1(1):1-3doi: 10.1002/ehf2.12004.
Anker, S. D., von Haehling, S., & Papp, Z. (2014). Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC heart failure, 1(1), 1-3. https://doi.org/10.1002/ehf2.12004
Anker, Stefan D, et al. "Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure." ESC heart failure vol. 1,1 (2014): 1-3. doi: https://doi.org/10.1002/ehf2.12004
Anker SD, von Haehling S, Papp Z. Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC Heart Fail. 2014 Sep;1(1):1-3. doi: 10.1002/ehf2.12004. PMID: 28834670.
Copy Download .nbib Format: NLM
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure.

Clinical proteomics

Cao TH, Jones DJL, Quinn PA, Chan DCS, Hafid N, Parry HM, Mohan M, Sandhu JK, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Metra M, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zannad F, Zwinderman AH, Voors AA, Lang CC, Ng LL.
PMID: 30410428
Clin Proteomics. 2018 Nov 02;15:35. doi: 10.1186/s12014-018-9213-1. eCollection 2018.

BACKGROUND: Current risk prediction models in heart failure (HF) including clinical characteristics and biomarkers only have moderate predictive value. The aim of this study was to use matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling to determine if...

Cite
Cao TH, Jones DJL, Quinn PA, et al. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clin Proteomics. 2018;15:35doi: 10.1186/s12014-018-9213-1.
Cao, T. H., Jones, D. J. L., Quinn, P. A., Chan, D. C. S., Hafid, N., Parry, H. M., Mohan, M., Sandhu, J. K., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Voors, A. A., Lang, C. C., & Ng, L. L. (2018). Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical proteomics, 1535. https://doi.org/10.1186/s12014-018-9213-1
Cao, Thong Huy, et al. "Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure." Clinical proteomics vol. 15 (2018): 35. doi: https://doi.org/10.1186/s12014-018-9213-1
Cao TH, Jones DJL, Quinn PA, Chan DCS, Hafid N, Parry HM, Mohan M, Sandhu JK, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Metra M, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zannad F, Zwinderman AH, Voors AA, Lang CC, Ng LL. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clin Proteomics. 2018 Nov 02;15:35. doi: 10.1186/s12014-018-9213-1. eCollection 2018. PMID: 30410428; PMCID: PMC6214161.
Copy Download .nbib Format: NLM
Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients.

Clinical kidney journal

Malyszko J, Anker SD.
PMID: 29225820
Clin Kidney J. 2017 Dec;10:i25-i31. doi: 10.1093/ckj/sfx070. Epub 2017 Nov 28.

Iron deficiency anaemia is a global health problem that manifests as fatigue and poor physical endurance. Anaemia can be caused by dietary iron deficiency, blood loss or a combination of poor iron absorption and ineffective iron mobilization in patients...

Cite
Malyszko J, Anker SD. Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients. Clin Kidney J. 2017;10:i25-i31doi: 10.1093/ckj/sfx070.
Malyszko, J., & Anker, S. D. (2017). Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients. Clinical kidney journal, 10i25-i31. https://doi.org/10.1093/ckj/sfx070
Malyszko, Jolanta, and Anker, Stefan D. "Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients." Clinical kidney journal vol. 10 (2017): i25-i31. doi: https://doi.org/10.1093/ckj/sfx070
Malyszko J, Anker SD. Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients. Clin Kidney J. 2017 Dec;10:i25-i31. doi: 10.1093/ckj/sfx070. Epub 2017 Nov 28. PMID: 29225820; PMCID: PMC5716152.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 455 entries